title: Ovarian hyperstimulation syndrome following the sole administration of injectable gonadotropin-releasing hormone agonist (triptorelin) for the pituitary down-regulation and in vitro fertilization treatment: report of two cases.
abstract: This report is to illustrate two cases of ovarian hyperstimulation syndrome following the sole administration of injectable mid-luteal gonadotropin-releasing hormone agonists (triptorelin) for pituitary down-regulation. Both women underwent egg retrieval, and despite the transfer of good quality embryos, no pregnancy was achieved. The possible mechanism and management of the condition were discussed.
authors.affiliation: Department of Obstetrics and Gynecology, IVF Center, Prince Rashed Hospital, Royal Medical Services, Irbid-Aidoun, Jordan. hqublan@yahoo.com
authors.forename: Hussein S
authors.initials: HS
authors.lastname: Qublan
authors.forename: Zakarya
authors.initials: Z
authors.lastname: Beni-Merei
authors.forename: Mohamad
authors.initials: M
authors.lastname: Megdadi
authors.forename: Gassan
authors.initials: G
authors.lastname: Al-Quraan
mesh_terms: D000328:Adult; D004624:Embryo Transfer; D004958:Estradiol / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007246:Infertility / Q000628:therapy; D007986:Luteinizing Hormone / Q000097:blood; D006080:Ovarian Follicle / Q000000981:diagnostic imaging; D016471:Ovarian Hyperstimulation Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D011374:Progesterone / Q000097:blood; D017211:Treatment Failure; D017329:Triptorelin Pamoate / Q000009:adverse effects*; D014463:Ultrasonography
chemical_list: D017329:Triptorelin Pamoate; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone